Alexza Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Alexza Pharmaceuticals ( ALXA) is a pharmaceutical company focused on the research, development and commercialization of products for the acute treatment of central nervous system conditions. This stock is trading up 3.2% at $4.68 in recent trading.

Today's Range: $4.59-$4.78

52-Week Range: $2.55-$14.80

Volume: 163,000

Three-Month Average Volume: 451,702

From a technical perspective, ALXA is trending higher here with light volume. This move is quickly pushing ALXA within range of triggering a major breakout trade. That trade will hit once ALXA manages to clear some near-term overhead resistance levels at $4.85 to $5.33 with high volume.

Traders should now look for long-biased trades in ALXA as long as it's trending above $4.40, and then once it sustains a move or close above those breakout levels with volume that's near or above 451,702 shares. If that breakout triggers soon, then look for ALXA to tag its next major overhead resistance levels at $6 to $7 in the near future.

To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under-$10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to and maintains the website, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.

If you liked this article you might like

3 Stocks Pushing The Drugs Industry Lower

Market News: Apple Inc, Vitae Pharmaceuticals, Alexza Pharmaceuticals

Why to Buy These 5 Under-$10 Stocks ASAP

5 Stocks Under $10 Set to Soar

7 Under-$10 Stocks Racing Higher